Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-08FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original-application generic product of a fixed-dose topical combination of adapalene and benzoyl peroxide for a…
-
FDA approval · 2019-11-07FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) filed by Sun Pharmaceutical Industries, expanding/updating the drug’…
-
FDA approval · 2019-11-05FDA Approved: ABSORICA LD — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved ABSORICA LD (isotretinoin) from Sun Pharmaceutical Industries as an original application, establishing a low-dose isotretinoin …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne [Phase 2]
Phase 2 clinical trial update for CJM112 in moderate to severe inflammatory acne completed with posted results.
-
FDA approval · 2019-10-04FDA Approved: AKLIEF — Original Application (Galderma Laboratories, L.P.)
FDA approved AKLIEF (trifarotene) by Galderma Laboratories for the treatment of acne vulgaris, including facial and truncal acne.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-10-03Clinical Trial Update: Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris
A completed clinical trial evaluating the role of Propionibacterium acnes in inflammatory lesions of acne vulgaris; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris [Phase 2]
Phase 2 clinical trial update for VB-1953 topical gel in inflammatory facial acne vulgaris evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris [Phase 2]
Phase 2 trial update assessing the efficacy, safety, and tolerability of S6G5T-1 and S6G5T-3 for acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris [Phase 3]
Long-term safety study of trifarotene (CD5789) in acne vulgaris completed; results posted in 2019.
-
FDA approval · 2019-09-10FDA Approved: ACZONE — Supplemental Application (Almirall, LLC)
FDA approved a supplemental application for ACZONE (dapsone) submitted by Almirall, LLC. The approval updates the product's labeling.
-
FDA approval · 2019-09-09FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals' generic clindamycin phosphate and benzoyl peroxide topical product for acne vulgaris under …
-
CLINICAL_TRIALS trial_result · 2019-09-03Clinical Trial Update: Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of CD5789 (trifarotene) 50 µg/g cream versus vehicle in acne vulgaris has complete…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of CD5789 (trifarotene) 50 μg/g cream versus vehicle in acne vulgaris with results po…
-
FDA approval · 2019-08-19FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals' clindamycin phosphate and benzoyl peroxide as an original application product for acne vulgaris.
-
FDA approval · 2019-08-19FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' generic topical combination of clindamycin phosphate and benzoyl peroxide (ANDA 206575) for …
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Comparing OTC Acne Treatment to Prescription Regimen [NA]
A completed clinical trial comparing an over-the-counter acne treatment to a prescription regimen for acne vulgaris, with results posted in …
-
FDA approval · 2019-07-09FDA Approved: ADAPALENE — Supplemental Application (TOP CARE (Topco Associates LLC))
FDA approved a supplemental application for adapalene from Top Care (Topco Associates LLC), updating the approved product listing for adapal…
-
FDA approval · 2019-07-08FDA Approved: ADAPALENE — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for adapalene, approving a generic version of the acne treatment.
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris [Phase 2]
Phase 2 study evaluating safety and efficacy of UHE-101 Cream in acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel [Phase 1, Phase 2]
Phase 1/2 trial of DRM01B topical gel for acne vulgaris completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: "Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy" [Phase 2, Phase 3]
A completed clinical trial evaluating the efficacy of vitamin D for acne therapy across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris [Phase 3]
Phase 3 bioequivalence study of Adapalene Gel 0.3% in subjects with facial acne vulgaris has completed.
-
FDA approval · 2019-04-09FDA Approved: SEYSARA — Supplemental Application (Almirall, LLC)
The FDA has approved a supplemental application for SEYSARA (sarecycline hydrochloride) from Almirall, LLC.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne [Phase 1, Phase 2]
Clinical trial evaluating the clinical effect of Daily Next Science Acne Gel (NAG) on mild to moderate facial acne completed (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients [Phase 4]
Phase 4 clinical trial update examining anti-inflammatory effects of topical erythromycin and clindamycin in acne patients.